BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 29194189)

  • 1. Ovarian Yolk Sac Tumors; Does Age Matter?
    Faure Conter C; Xia C; Gershenson D; Hurteau J; Covens A; Pashankar F; Krailo M; Billmire D; Patte C; Fresneau B; Shaikh F; Stoneham S; Nicholson J; Murray M; Frazier AL
    Int J Gynecol Cancer; 2018 Jan; 28(1):77-84. PubMed ID: 29194189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcome and prognostic factors for yolk sac tumor of the ovary.
    Umezu T; Kajiyama H; Terauchi M; Shibata K; Ino K; Nawa A; Kikkawa F
    Nagoya J Med Sci; 2008 Mar; 70(1-2):29-34. PubMed ID: 18807293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yolk sac tumours of the ovary: evaluation of clinicopathological features and prognostic factors.
    Cicin I; Saip P; Guney N; Eralp Y; Ayan I; Kebudi R; Topuz E
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):210-4. PubMed ID: 19419810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian endometrioid tumors with yolk sac tumor component, an unusual form of ovarian neoplasm. Analysis of six cases.
    Nogales FF; Bergeron C; Carvia RE; Alvaro T; Fulwood HR
    Am J Surg Pathol; 1996 Sep; 20(9):1056-66. PubMed ID: 8764742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: a report of the pediatric oncology group and the children's cancer group.
    Cushing B; Giller R; Ablin A; Cohen L; Cullen J; Hawkins E; Heifetz SA; Krailo M; Lauer SJ; Marina N; Rao PV; Rescorla F; Vinocur CD; Weetman RM; Castleberry RP
    Am J Obstet Gynecol; 1999 Aug; 181(2):353-8. PubMed ID: 10454682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging in gynecological disease (17): ultrasound features of malignant ovarian yolk sac tumors (endodermal sinus tumors).
    Anfelter P; Testa A; Chiappa V; Froyman W; Fruscio R; Guerriero S; Alcazar JL; Mascillini F; Pascual MA; Sibal M; Savelli L; Zannoni GF; Timmerman D; Epstein E
    Ultrasound Obstet Gynecol; 2020 Aug; 56(2):276-284. PubMed ID: 32119168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yolk sac tumor of the ovary: a retrospective multicenter study of 33 Japanese women by Tohoku Gynecologic Cancer Unit (TGCU).
    Kojimahara T; Nakahara K; Takano T; Yaegashi N; Nishiyama H; Fujimori K; Sato N; Terada Y; Tase T; Yokoyama Y; Mizunuma H; Shoji T; Sugiyama T; Kurachi H
    Tohoku J Exp Med; 2013 Aug; 230(4):211-7. PubMed ID: 23912096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revised risk classification for pediatric extracranial germ cell tumors based on 25 years of clinical trial data from the United Kingdom and United States.
    Frazier AL; Hale JP; Rodriguez-Galindo C; Dang H; Olson T; Murray MJ; Amatruda JF; Thornton C; Arul GS; Billmire D; Shaikh F; Pashankar F; Stoneham S; Krailo M; Nicholson JC
    J Clin Oncol; 2015 Jan; 33(2):195-201. PubMed ID: 25452439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of HNF1β in the differential diagnosis of yolk sac tumor from other germ cell tumors.
    Rougemont AL; Tille JC
    Hum Pathol; 2018 Nov; 81():26-36. PubMed ID: 29753846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of standard-dose BEP regimen (bleomycin+etoposide+cisplatin) is essential for treatment of ovarian yolk sac tumour.
    Satoh T; Aoki Y; Kasamatsu T; Ochiai K; Takano M; Watanabe Y; Kikkawa F; Takeshima N; Hatae M; Yokota H; Saito T; Yaegashi N; Kobayashi H; Baba T; Kodama S; Saito T; Sakuragi N; Sumi T; Kamura T; Yoshikawa H
    Eur J Cancer; 2015 Feb; 51(3):340-51. PubMed ID: 25559616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors of patients with yolk sac tumors of the ovary.
    Nawa A; Obata N; Kikkawa F; Kawai M; Nagasaka T; Goto S; Nishimori K; Nakashima N
    Am J Obstet Gynecol; 2001 May; 184(6):1182-8. PubMed ID: 11349186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary germ cell tumors of the mediastinum: III. Yolk sac tumor, embryonal carcinoma, choriocarcinoma, and combined nonteratomatous germ cell tumors of the mediastinum--a clinicopathologic and immunohistochemical study of 64 cases.
    Moran CA; Suster S; Koss MN
    Cancer; 1997 Aug; 80(4):699-707. PubMed ID: 9264353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management and prognosis of ovarian yolk sac tumors; an analysis of the National Cancer Data Base.
    Nasioudis D; Chapman-Davis E; Frey MK; Caputo TA; Holcomb K
    Gynecol Oncol; 2017 Nov; 147(2):296-301. PubMed ID: 28803748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of nondysgerminomatous ovarian germ cell tumors: an analysis of 69 cases.
    Mitchell PL; Al-Nasiri N; A'Hern R; Fisher C; Horwich A; Pinkerton CR; Shepherd JH; Gallagher C; Slevin M; Harper P; Osborne R; Mansi J; Oliver T; Gore ME
    Cancer; 1999 May; 85(10):2232-44. PubMed ID: 10326703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults?
    Shah R; Xia C; Krailo M; Amatruda JF; Arul SG; Billmire DF; Brady WE; Covens A; Gershenson DM; Hale JP; Hurteau J; Murray MJ; Nicholson JC; Olson TA; Pashankar F; Rodriguez-Galindo C; Shaikh F; Stark D; Frazier AL; Stoneham S
    Gynecol Oncol; 2018 Aug; 150(2):253-260. PubMed ID: 29884437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of ovarian endometrioid adenocarcinoma with a yolk sac tumor component.
    Abe A; Furumoto H; Yoshida K; Nishimura M; Irahara M; Kudo E; Sano T
    Int J Gynecol Cancer; 2008; 18(1):168-72. PubMed ID: 17466041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian yolk sac tumors in older women arising from epithelial ovarian tumors or with no detectable epithelial component.
    Roth LM; Talerman A; Levy T; Sukmanov O; Czernobilsky B
    Int J Gynecol Pathol; 2011 Sep; 30(5):442-51. PubMed ID: 21804392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and Characterization of a Novel Primitive Yolk Sac Tumour Cell Line, TC587.
    Iwasaki T; Kohashi K; Ohno M; Taguchi T; Oda Y
    Anticancer Res; 2020 Feb; 40(2):759-766. PubMed ID: 32014918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of an early decline in serum alpha-fetoprotein during chemotherapy for ovarian yolk sac tumors.
    de la Motte Rouge T; Pautier P; Genestie C; Rey A; Gouy S; Leary A; Haie-Meder C; Kerbrat P; Culine S; Fizazi K; Lhommé C
    Gynecol Oncol; 2016 Sep; 142(3):452-7. PubMed ID: 27401840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian yolk sac tumor in postmenopausal females: a report of five cases and a literature review.
    Wang X; He J; Li Y
    Eur J Gynaecol Oncol; 2016; 37(3):374-9. PubMed ID: 27352567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.